Moon J. du Bois R.M. Colby T.V. et al.

Clinical significance of respiratory bronchiolitis on open lung biopsy and its relationship to smoking related interstitial lung disease.

Thorax. 54: 1009-1014Ryu J.H. Colby T.V. Hartman T.E. et al.

Smoking-related interstitial lung diseases: a concise review.

Eur Respir J. 17: 122Emile J.F. Abla O. Fraitag S. et al.

Revised classification of histiocytoses and neoplasms of the macrophage-dendritic cell lineages.

Blood. 127: 2672-2681Kobayashi M. Ando S. Kawamata T. et al.

Clinical features and outcomes of adult Langerhans cell histiocytosis: a single-center experience.

Int J Hematol. 112: 185-192Tazi A. de Margerie C. Naccache J.M. et al.

The natural history of adult pulmonary Langerhans cell histiocytosis: a prospective multicentre study.

Orphanet J Rare Dis. 10: 30Vassallo R. Ryu J.H. Schroeder D.R. et al.

Clinical outcomes of pulmonary langerhans'-cell histiocytosis in adults.

N Engl J Med. 346: 484-490

Histiocytosis X in the lung.

Hum Pathol. 14: 847-856Badalian-Very G. Vergilio J.-A. Degar B.A. et al.

Recurrent BRAF mutations in Langerhans cell histiocytosis.

Blood. 116: 1919-1923Roden A.C. Hu X. Kip S. et al.

BRAF V600E expression in Langerhans cell histiocytosis: clinical and immunohistochemical study on 25 pulmonary and 54 extrapulmonary cases.

Am J Surg Pathol. 38: 548-551Liu H. Osterburg A.R. Flury J. et al.

MAPK mutations and cigarette smoke promote the pathogenesis of pulmonary Langerhans cell histiocytosis.

JCI Insight. 5https://doi.org/10.1172/jci.insight.132048Vassallo R. Harari S. Tazi A.

Current understanding and management of pulmonary Langerhans cell histiocytosis.

Thorax. 72: 937-945Travis W.D. Borok Z. Roum J.H. et al.

Pulmonary Langerhans cell granulomatosis (histiocytosis X). A clinicopathologic study of 48 cases.

Am J Surg Pathol. 17: 971-986Mendez J.L. Nadrous H.F. Vassallo R. et al.

Pneumothorax in pulmonary Langerhans cell histiocytosis.

Chest. 125: 1028-1032Radzikowska E. Błasińska-Przerwa K. Wiatr E. et al.

Pneumothorax in Patients with Pulmonary Langerhans Cell Histiocytosis.

Lung. 196: 715-720Le Guen P. Chevret S. Bugnet E. et al.

Management and outcomes of pneumothorax in adult patients with Langerhans cell Histiocytosis.

Orphanet J Rare Dis. 14: 229Tazi A. Marc K. Dominique S. et al.

Serial computed tomography and lung function testing in pulmonary Langerhans’ cell histiocytosis.

Eur Respir J. 40: 905Lacronique J. Roth C. Battesti J.P. et al.

Chest radiological features of pulmonary histiocytosis X: a report based on 50 adult cases.

Thorax. 37: 104-109Brauner M.W. Grenier P. Mouelhi M.M. et al.

Pulmonary histiocytosis X: evaluation with high-resolution CT.

Radiology. 172: 255-258Auerswald U. Barth J. Magnussen H.

Value of CD-1-positive cells in bronchoalveolar lavage fluid for the diagnosis of pulmonary histiocytosis X.

Lung. 169: 305-309Goyal G. Tazi A. Go R.S. et al.

International expert consensus recommendations for the diagnosis and treatment of Langerhans cell histiocytosis in adults.

Blood. 139: 2601-2621Baqir M. Vassallo R. Maldonado F. et al.

Utility of bronchoscopy in pulmonary Langerhans cell histiocytosis.

J Bronchology Interv Pulmonol. 20: 309-312Barata M. Caetano Mota P. Melo N. et al.

Transbronchial lung cryobiopsy in smoking-related interstitial lung diseases.

Sarcoidosis Vasc Diffuse Lung Dis. 37: e2020013Chaowalit N. Pellikka P.A. Decker P.A. et al.

Echocardiographic and clinical characteristics of pulmonary hypertension complicating pulmonary langerhans cell histiocytosis.

Mayo Clinic Proc. 79: 1269-1275

Pulmonary langerhans cell histiocytosis: an update from the pathologists' perspective.

Arch Pathol Lab Med. 140: 230-240Benattia A. Bugnet E. Walter-Petrich A. et al.

Long-term outcomes of adult pulmonary Langerhans cell histiocytosis: a prospective cohort.

Eur Respir J. 59https://doi.org/10.1183/13993003.01017-2021Delobbe A. Durieu J. Duhamel A. et al.

Determinants of survival in pulmonary Langerhans' cell granulomatosis (histiocytosis X). Groupe d'Etude en Pathologie Interstitielle de la Société de Pathologie Thoracique du Nord.

Eur Respir J. 9: 2002-2006Grobost V. Khouatra C. Lazor R. et al.

Effectiveness of cladribine therapy in patients with pulmonary Langerhans cell histiocytosis.

Orphanet J Rare Dis. 9: 191Le Pavec J. Lorillon G. Jaïs X. et al.

Pulmonary Langerhans cell histiocytosis-associated pulmonary hypertension: clinical characteristics and impact of pulmonary arterial hypertension therapies.

Chest. 142: 1150-1157Dauriat G. Mal H. Thabut G. et al.

Lung transplantation for pulmonary langerhans' cell histiocytosis: a multicenter analysis.

Transplantation. 81: 746-750Niewoehner D.E. Kleinerman J. Rice D.B.

Pathologic changes in the peripheral airways of young cigarette smokers.

N Engl J Med. 291: 755-758Fraig M. Shreesha U. Savici D. et al.

Respiratory bronchiolitis: a clinicopathologic study in current smokers, ex-smokers, and never-smokers.

Am J Surg Pathol. 26: 647-653Wright J.L. Lawson L.M. Pare P.D. et al.

Morphology of peripheral airways in current smokers and ex-smokers.

Am Rev Respir Dis. 127: 474-477Cosio M.G. Hale K.A. Niewoehner D.E.

Morphologic and morphometric effects of prolonged cigarette smoking on the small airways.

Am Rev Respir Dis. 122: 265-271Myers J.L. Veal Jr., C.F. Shin M.S. et al.

Respiratory bronchiolitis causing interstitial lung disease. A clinicopathologic study of six cases.

Am Rev Respir Dis. 135: 880-884Ryu J.H. Myers J.L. Capizzi S.A. et al.

Desquamative interstitial pneumonia and respiratory bronchiolitis-associated interstitial lung disease.

Chest. 127: 178-184Craig P.J. Wells A.U. Doffman S. et al.

Desquamative interstitial pneumonia, respiratory bronchiolitis and their relationship to smoking.

Histopathology. 45: 275-282Yousem S.A. Colby T.V. Gaensler E.A.

Respiratory bronchiolitis-associated interstitial lung disease and its relationship to desquamative interstitial pneumonia.

Mayo Clin Proc. 64: 1373-1380

Respiratory bronchiolitis-associated interstitial lung disease with fibrosis is a lesion distinct from fibrotic nonspecific interstitial pneumonia: a proposal.

Mod Pathol. 19: 1474-1479Portnoy J. Veraldi K.L. Schwarz M.I. et al.

Respiratory bronchiolitis-interstitial lung disease: long-term outcome.

Chest. 131: 664-671Park J.S. Brown K.K. Tuder R.M. et al.

Respiratory bronchiolitis-associated interstitial lung disease: radiologic features with clinical and pathologic correlation.

J Comput Assist Tomogr. 26: 13-20Solaymani-Dodaran M. West J. Smith C. et al.

Extrinsic allergic alveolitis: incidence and mortality in the general population.

QJM: An Int J Med. 100: 233-237Agius R.M. Rutman A. Knight R.K. et al.

Human pulmonary alveolar macrophages with smokers' inclusions: their relation to the cessation of cigarette smoking.

Br J Exp Pathol. 67: 407-413Nakanishi M. Demura Y. Mizuno S. et al.

Changes in HRCT findings in patients with respiratory bronchiolitis-associated interstitial lung disease after smoking cessation.

Eur Respir J. 29: 453-461Liebow A.A. Steer A. Billingsley J.G.

Desquamative Interstitial Pneumonia.

Am J Med. 39: 369-404

American Thoracic Society/European Respiratory Society International Multidisciplinary Consensus Classification of the Idiopathic Interstitial Pneumonias.

Am J Resp Crit Care. 165: 277-304Hellemons M.E. Moor C.C. von der Thusen J. et al.

Desquamative interstitial pneumonia: a systematic review of its features and outcomes.

Eur Respir Rev. 29https://doi.org/10.1183/16000617.0181-2019Abraham J.L. Hertzberg M.A.

Inorganic particulates associated with desquamative interstitial pneumonia.

Chest. 80: 67-70Godbert B. Wissler M.P. Vignaud J.M.

Desquamative interstitial pneumonia: an analytic review with an emphasis on aetiology.

Eur Respir Rev. 22: 117-123Ishii H. Iwata A. Sakamoto N. et al.

Desquamative interstitial pneumonia (DIP) in a patient with rheumatoid arthritis: is DIP associated with autoimmune disorders?.

Intern Med. 48: 827-830Ong S. Levy R.D. Yee J. et al.

Successful lung transplantation in an HIV seropositive patient with desquamative interstitial pneumonia: a case report.

BMC Pulm Med. 18: 162Hasegawa H. Nakamura Y. Kaida Y. et al.

[A case of desquamative interstitial pneumonia associated with hepatitis C virus infection].

Nihon Kokyuki Gakkai Zasshi. 47: 698-703Sung S.A. Ko G.J. Kim J.Y. et al.

Desquamative interstitial pneumonia associated with concurrent cytomegalovirus and Aspergillus pneumonia in a renal transplant recipient.

Nephrol Dial Transpl. 20: 635-638Schroten H. Manz S. Köhler H. et al.

Fatal desquamative interstitial pneumonia associated with proven CMV infection in an 8-month-old boy.

Pediatr Pulmonol. 25: 345-347Iskandar S.B. McKinney L.A. Shah L. et al.

Desquamative interstitial pneumonia and hepatitis C virus infection: a rare association.

South Med J. 97: 890-893Buchino J.J. Keenan W.J. Algren J.T. et al.

Familial desquamative interstitial pneumonitis occurring in infants.

Am J Med Genet Suppl. 3: 285-291Stillwell P.C. Norris D.G. O'Connell E.J. et al.

Desquamative interstitial pneumonitis in children.

Chest. 77: 165-171Carrington C.B. Gaensler E.A. Coutu R.E. et al.

Natural history and treated course of usual and desquamative interstitial pneumonia.

N Engl J Med. 298: 801-809Hartman T.E. Primack S.L. Kang E.Y. et al.

Disease progression in usual interstitial pneumonia compared with desquamative interstitial pneumonia.

Assess serial CT. Chest. 110: 378-382Akira M. Yamamoto S. Hara H. et al.

Serial computed tomographic evaluation in desquamative interstitial pneumonia.

Thorax. 52: 333-337Kawabata Y. Takemura T. Hebisawa A. et al.

Eosinophilia in bronchoalveolar lavage fluid and architectural destruction are features of desquamative interstitial pneumonia.

Histopathology. 52: 194-202

A Review of Smoking-Related Interstitial Fibrosis, Respiratory Bronchiolitis, and Desquamative Interstitial Pneumonia: Overlapping Histology and Confusing Terminology.

Arch Pathol Lab Med. 142: 1177-1181Carrington C.B. Gaensler E.A. Coutu R.E. et al.

Usual and desquamative interstitial pneumonia.

Chest. 69: 261-263Allen J.N. Pacht E.R. Gadek J.E. et al.

Acute eosinophilic pneumonia as a reversible cause of noninfectious respiratory failure.

N Engl J Med. 321: 569-574Badesch D.B. King Jr., T.E. Schwarz M.I.

Acute eosinophilic pneumonia: a hypersensitivity phenomenon?.

Am Rev Respir Dis. 139: 249-252Uchiyama H. Suda T. Nakamura Y. et al.

Alterations in smoking habits are associated with acute eosinophilic pneumonia.

Chest. 133: 1174-1180

Acute eosinophilic pneumonia associated with non-cigarette smoking products: a systematic review.

Adv Respir Med. 88: 142-146Rom W.N. Weiden M. Garcia R. et al.

Acute eosinophilic pneumonia in a New York City firefighter exposed to World Trade Center dust.

Am J Respir Crit Care Med. 166: 797-800Cherian S.V. Sardinas G. Al Salihi S.A. et al.

A 62-year-old man with cough and dyspnea after crack cocaine inhalation.

Ann Am Thorac Soc. 13: 1416-1418De Giacomi F. Vassallo R. Yi E.S. et al.

Acute eosinophilic pneumonia. causes, diagnosis, and management.

Am J Respir Crit Care Med. 197: 728-736

Cocaine induced eosinophilic lung disease.

Thorax. 47: 478-479Bartal C. Sagy I. Barski L.

Drug-induced eosinophilic pneumonia: a review of 196 case reports.

Medicine (Baltimore). 97: e9688De Giacomi F. Decker P.A. Vassallo R. et al.

Acute eosinophilic pneumonia: correlation of clinical characteristics with underlying cause.

Chest. 152: 379-385Higashi Y. Nakamura S. Tsuji Y. et al.

Daptomycin-induced eosinophilic pneumonia and a review of the published literature.

Intern Med. 57: 253-258Buelow B.J. Kelly B.T. Zafra H.T. et al.

Absence of Peripheral Eosinophilia on Initial Clinical Presentation Does Not Rule Out the Diagnosis of Acute Eosinophilic Pneumonia.

J Allergy Clin Immunol Pract. 3: 597-598Choi J.Y. Lim J.U. Jeong H.J. et al.

Association between peripheral blood/bronchoalveolar lavage eosinophilia and significant oxygen requirements in patients with acute eosinophilic pneumonia.

BMC Pulm Med. 20: 22Daimon T. Johkoh T. Sumikawa H. et al.

Acute eosinophilic pneumonia: Thin-section CT findings in 29 patients.

Eur J Radiol. 65: 462-467Tazelaar H.D. Linz L.J. Colby T.V. et al.

Acute eosinophilic pneumonia: histopathologic findings in nine patients.

Am J Respir Crit Care Med. 155: 296-302Rhee C.K. Min K.H. Yim N.Y. et al.

Clinical characteristics and corticosteroid treatment of acute eosinophilic pneumonia.

Eur Respir J. 41: 402-409Philit F. Etienne-Mastroianni B. Parrot A. et al.

Idiopathic acute eosinophilic pneumonia: a study of 22 patients.

Am J Respir Crit Care Med. 166: 1235-1239

Combined pulmonary fibrosis and emphysema: bad and ugly all the same?.

Eur Respir J. 50https://doi.org/10.1183/13993003.00846-2017Cottin V. Selman M. Inoue Y. et al.

Syndrome of Combined Pulmonary Fibrosis and Emphysema: An Official ATS/ERS/JRS/ALAT Research Statement.

Am J Respir Crit Care Med. 206: e7-e41Cottin V. Nunes H. Brillet P.Y. et al.

Combined pulmonary fibrosis and emphysema: a distinct underrecognised entity.

Eur Respir J. 26: 586-593Nemoto M. Koo C.W. Ryu J.H.

Diagnosis and Treatment of Combined Pulmonary Fibrosis and Emphysema in 2022.

JAMA. 328: 69-70Mejia M. Carrillo G. Rojas-Serrano J. et al.

Idiopathic pulmonary fibrosis and emphysema: decreased survival associated with severe pulmonary arterial hypertension.

Chest. 136: 10-15Hage R. Gautschi F. Steinack C. et al.

Combined Pulmonary Fibrosis and Emphysema (CPFE) Clinical Features and Management.

Int J Chron Obstruct Pulmon Dis. 16: 167-177Kim H.J. Snyder L.D. Neely M.L. et al.

Clinical Outcomes of Patients with Combined Idiopathic Pulmonary Fibrosis and Emphysema in the IPF-PRO Registry.

Lung. 200: 21-29Ryerson C.J. Hartman T. Elicker B.M. et al.

Clinical features and outcomes in combined pulmonary fibrosis and emphysema in idiopathic pulmonary fibrosis.

Chest. 144: 234-240Cottin V. Le Pavec J. Prevot G. et al.

Pulmonary hypertension in patients with combined pulmonary fibrosis and emphysema syndrome.

Eur Respir J. 35: 105-111

Pulmonary hypertension in combined pulmonary fibrosis and emphysema: a tale of two cities.

Respirology. 23: 556-557Jacob J. Bartholmai B.J. Rajagopalan S. et al.

Likelihood of pulmonary hypertension in patients with idiopathic pulmonary fibrosis and emphysema.

Respirology. 23: 593-599Chung J.H. Richards J.C. Koelsch T.L. et al.

Screening for lung cancer: incidental pulmonary parenchymal findings.

AJR Am J Roentgenol. 210: 503-513Tanner N.T. Thomas N.A. Ward R. et al.

Association of cigarette type with lung cancer incidence and mortality: secondary analysis of the national lung screening trial.

JAMA Intern Med. 179: 1710-1712Doyle T.J. Washko G.R. Fernandez I.E. et al.

Interstitial lung abnormalities and reduced exercise capacity.

Am J Respir Crit Care Med. 185: 756-762Ash S.Y. Harmouche R. Putman R.K. et al.

Clinical and genetic associations of objectively identified interstitial changes in smokers.

Chest. 152: 780-791Washko G.R. Hunninghake G.M. Fernandez I.E. et al.

Lung Volumes and Emphysema in Smokers with Interstitial Lung Abnormalities.

N Engl J Med. 364: 897-906Katzenstein A.L. Mukhopadhyay S. Zanardi C. et al.

Clinically occult interstitial fibrosis in smokers: classification and significance of a surprisingly common finding in lobectomy specimens.

Hum Pathol. 41: 316-325

Smoking-related interstitial fibrosis (SRIF), pathogenesis and treatment of usual interstitial pneumonia (UIP), and transbronchial biopsy in UIP.

Mod Pathol. 25: S68-S78Blanchet M.R. Israël-Assayag E. Cormier Y.

Inhibitory effect of nicotine on experimental hypersensitivity pneumonitis in vivo and in vitro.

Am J Respir Crit Care Med. 169: 903-909Douglas J.G. Middleton W.G. Gaddie J. et al.

Sarcoidosis: a disorder commoner in non-smokers?.

Thorax. 41: 787-791Rivera N.V. Patasova K. Kullberg S. et al.

A gene-environment interaction between smoking and gene polymorphisms provides a high risk of two subgroups of sarcoidosis.

Sci Rep. 9: 18633